Lifeward Ltd., formerly known as ReWalk Robotics, has unveiled its latest investor presentation, highlighting its innovative technologies aimed at transforming the lives of individuals with physical limitations or disabilities. The company has made significant strides with its ReWalk Personal Exoskeleton, which has received both FDA and CE approvals, and the AlterG Anti-Gravity Systems, utilizing NASA-derived Differential Air Pressure technology. Lifeward Ltd. is also expanding its market presence, particularly in the U.S. and Germany, with Medicare coverage in place since April 2024. The company is focusing on securing private insurance coverage to further grow its addressable market. Lifeward Ltd. is on a path to profitability, expecting to reduce operating losses in 2025 and achieve profitability by 2026. The full presentation can be accessed through the link below.